Lumigan vs Careprost: Are They Really the Same Drug?

If you have researched bimatoprost eyelash serums or glaucoma eye drops, you have almost certainly encountered both Lumigan and Careprost. The confusion between them is understandable: they share an active ingredient, look similar, and produce the same effect on eyelashes. But there are real differences in how they are approved, who makes them, and what they cost. This guide gives you the complete picture.

What Is Lumigan?

Lumigan is a brand-name bimatoprost ophthalmic solution 0.03% manufactured by Allergan (now part of AbbVie). It is FDA-approved for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. According to the FDA-approved DailyMed label, one drop is applied to the affected eye(s) once daily in the evening.

Lumigan was originally approved purely as a glaucoma medication. The eyelash growth effect, now widely known, was initially noticed as a side effect in glaucoma patients using bimatoprost eye drops: their eyelashes were growing longer, thicker, and darker. Allergan subsequently developed a separate product specifically for eyelash enhancement, marketed as Latisse, using the same 0.03% bimatoprost concentration.

What Is Careprost?

Careprost is a generic bimatoprost ophthalmic solution 0.03% manufactured in India by Sun Pharmaceutical Industries, one of the world's largest generic pharmaceutical manufacturers. It contains the same active ingredient (bimatoprost) at the same concentration (0.03%) as Lumigan.

Careprost is FDA-approved for use in India but is not FDA-approved in the United States, where it is classified as an unapproved generic. However, because it is bioequivalent to Lumigan and manufactured under regulatory oversight, it is widely used internationally and accessed through international pharmacies by US, UK, Australian, and Canadian patients primarily for off-label eyelash growth enhancement.

SafeRxPills carries Careprost 3ml bimatoprost 0.03% sourced from verified, WHO-GMP compliant supply chains.

Lumigan vs Careprost: Key Comparison

Do They Produce the Same Results?

Yes. The biological effect is driven entirely by the active ingredient: bimatoprost 0.03%. Both Lumigan and Careprost deliver the same concentration of the same molecule. The mechanism of action for eyelash growth is identical.

According to a 2024 comprehensive PubMed review of eyelash serums (PMID:38475901), bimatoprost's efficacy for eyelash enhancement is the best-supported by clinical evidence among all eyelash serum ingredients. The review noted that bimatoprost results are backed by numerous studies evaluating both safety and adverse effects, putting it in a class above non-prostaglandin alternatives.

For glaucoma treatment specifically, a 2015 network meta-analysis (PMID:26526633) of 114 randomised controlled trials including 20,275 participants ranked bimatoprost as the single most effective first-line IOP-lowering medication, producing a mean IOP reduction of 5.61mmHg at 3 months. This applies equally to Lumigan and any bioequivalent generic including Careprost.

How Does Bimatoprost Cause Eyelash Growth?

Bimatoprost is a prostaglandin analog, a synthetic compound that mimics the effects of naturally occurring prostaglandins. According to the FDA-approved DailyMed mechanism of action, bimatoprost selectively mimics prostamides. For intraocular pressure, it works by increasing aqueous humor outflow through both the trabecular meshwork and uveoscleral routes.

For eyelashes, the mechanism is different. Bimatoprost appears to shift eyelash hair follicles into an active growth phase (anagen) and prolong that phase, resulting in longer, thicker, and more numerous lashes. The exact molecular pathway remains an active area of research, but the clinical results are well-documented: in the original trials that led to Latisse approval, bimatoprost 0.03% produced a 25% increase in eyelash length, 106% increase in thickness, and 18% increase in darkness over 16 weeks.

For a complete guide on achieving maximum results, see our articles on how to apply Careprost correctly and Careprost eyelash results week by week.

What Are the Side Effects of Bimatoprost?

Because Lumigan and Careprost contain identical active ingredients, their side effect profiles are the same. The FDA label for bimatoprost 0.03% lists the following:

Common (3-45% of users in clinical trials)

• Conjunctival hyperemia (eye redness) — the most frequent, occurring in 15-45% of users
• Eyelash changes (growth, darkening, thickening) — often desired when using for cosmetic purposes
• Ocular pruritus (eye itching) — approximately 3-10% of users

Less Common (1-10%)

• Ocular dryness, foreign body sensation, eye pain
• Periorbital skin darkening (skin around the eyes may become slightly darker)
• Deepening of the upper eyelid sulcus (the groove above the eyelid can become more pronounced with prolonged use)

Important Warnings

The FDA label includes two specific warnings worth knowing:

• Iris pigmentation: In patients using bimatoprost for glaucoma (full-eye drop, not just lid-line application), permanent iris colour change is possible. The brown pigment around the pupil can spread over time. For eyelash use where bimatoprost is applied only to the upper eyelid skin with an applicator brush, this risk is much lower, but patients with mixed-colour irises should be aware of it.
• Contact lenses: Bimatoprost contains benzalkonium chloride, which can be absorbed by soft contact lenses. Remove lenses before applying and wait 15 minutes before reinserting.

For the full safety picture, see our Careprost complete eyelash guide and our Latisse vs bimatoprost comparison.

Lumigan vs Careprost vs Latisse: What Is the Difference?

This is where it gets slightly confusing because three products contain essentially the same ingredient:

• Lumigan 0.03%: Allergan brand, FDA-approved for glaucoma, comes in a standard multi-dose eye drop bottle
• Latisse 0.03%: Also Allergan brand, FDA-approved specifically for eyelash hypotrichosis (inadequate eyelashes), comes packaged with sterile applicator brushes for lid-line application, same 0.03% bimatoprost
• Careprost 0.03%: Sun Pharma generic, same active ingredient, approved in India, sold internationally, significantly lower cost

The practical difference between Lumigan and Latisse is purely packaging and marketing. Latisse costs more than Lumigan despite identical chemistry, because of the branded applicator brushes and the cosmetic positioning. Careprost provides the same chemistry at a fraction of the cost.

Which Should You Choose?

For glaucoma or ocular hypertension: your ophthalmologist will prescribe whichever is locally available and covered by your insurance. If cost is a barrier, Careprost from a verified international pharmacy is pharmacologically identical.

For eyelash enhancement: Careprost is the practical choice for most patients. It delivers the same bimatoprost 0.03% concentration for a fraction of the cost of Latisse. The key is sourcing from a reputable supplier with verified WHO-GMP manufacturing and proper cold-chain shipping.

SafeRxPills supplies Careprost 3ml, Careprost Plus, and Lumigan eye drops. All sourced from verified WHO-GMP certified supply chains.

How to Apply Bimatoprost for Eyelash Growth

Whether using Lumigan or Careprost for eyelash enhancement, the application method is the same:

1. Remove makeup and contact lenses
2. Using a sterile applicator brush, apply one drop of solution to the brush tip
3. Draw the brush along the base of the upper eyelid lash line, from inner corner to outer corner
4. Blot any excess solution that runs onto the lower lid or cheek with a tissue
5. Do not apply to the lower lash line directly (some solution will transfer naturally)
6. Replace lenses after 15 minutes
7. Apply once daily, preferably in the evening

Results appear gradually. Most users see noticeable change from week 4 to 8, with maximum results at 12 to 16 weeks. See our week-by-week Careprost results guide for a realistic timeline.

Key Takeaways

• Lumigan and Careprost contain the same active ingredient: bimatoprost 0.03%. They produce identical biological effects.
• Lumigan is FDA-approved in the US; Careprost is an Indian-manufactured generic not FDA-approved in the US but used internationally
• For eyelash growth, both work identically. Careprost is 10-20x cheaper than Lumigan or Latisse
• Key side effects to know: eye redness (common, usually mild), possible skin darkening around eyes, and permanent iris pigmentation risk when used as full eye drops for glaucoma
• Remove contact lenses before applying; wait 15 minutes before reinserting
• Apply only to the upper eyelid lash line with a sterile brush; never directly to the lower lid

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Bimatoprost ophthalmic solution requires a prescription in most countries. If you have glaucoma or ocular hypertension, treatment decisions should be made with an ophthalmologist. For cosmetic eyelash use, consult a healthcare provider if you have existing eye conditions.